SEC Filings

10-Q
ENVISION HEALTHCARE CORP filed this Form 10-Q on 11/03/2017
Entire Document
 
Item 1. Financial Statements - (continued)

Envision Healthcare Corporation
Consolidated Statements of Changes in Equity (unaudited)
(Dollars in millions, shares in thousands)
 
Envision Healthcare Corporation Stockholders
 
 
 
 
 
Noncontrolling
 
 
 
 
 
 
 
 
 
 
 
Accumulated
 
Noncontrolling
 
 
 
Interests –
 
 
 
 
 
 
 
Additional
 
 
 
Other
 
Interests –
 
Total
 
Redeemable
 
Common Stock
 
Preferred Stock
 
Paid-in
 
Retained
 
Comprehensive
 
Non-
 
Equity
 
(Temporary
 
Shares
 
Amount
 
Shares
 
Amount
 
Capital
 
Earnings
 
Income (Loss)
 
Redeemable
 
(Permanent)
 
Equity)
Balance at December 31, 2016
117,478

 
$
1.2

 
1,725

 
$
0.1

 
$
5,976.3

 
$
753.7

 
$
(0.2
)
 
$
656.8

 
$
7,387.9

 
$
182.9

Net earnings (loss)

 

 

 

 

 
(360.6
)
 

 
51.4

 
(309.2
)
 
105.0

Issuance of restricted stock
45

 

 

 

 

 

 

 

 

 

Conversion of preferred stock
3,128

 

 
(1,725
)
 
(0.1
)
 
0.1

 

 

 

 

 

Stock options exercised
416

 

 

 

 
4.0

 

 

 

 
4.0

 

Stock repurchased
(178
)
 

 

 

 
(9.4
)
 

 

 

 
(9.4
)
 

Share-based compensation

 

 

 

 
40.4

 

 

 

 
40.4

 

Dividends paid on preferred stock

 

 

 

 

 
(4.5
)
 

 

 
(4.5
)
 

Acquisitions and other transactions impacting noncontrolling interests

 

 

 

 
0.8

 

 

 
24.7

 
25.5

 
(0.5
)
Distributions to noncontrolling interests, net of capital contributions

 

 

 

 

 

 

 
(63.0
)
 
(63.0
)
 
(110.3
)
Disposals and other transactions impacting noncontrolling interests

 

 

 

 
(11.9
)
 

 

 
(3.8
)
 
(15.7
)
 
8.0

Unrealized holding gain on investments, net of income tax

 

 

 

 

 

 
1.3

 

 
1.3

 

Balance at September 30, 2017
120,889

 
$
1.2

 

 
$


$
6,000.3

 
$
388.6

 
$
1.1

 
$
666.1

 
$
7,057.3

 
$
185.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at January 1, 2016
54,294

 
$
1,345.4

 
1,725

 
$
166.6

 
$

 
$
781.4

 
$

 
$
471.3

 
$
2,764.7

 
$
175.7

Net earnings

 

 

 

 

 
116.9

 

 
54.2

 
171.1

 
112.3

Issuance of restricted stock
587

 

 

 

 

 

 

 

 

 

Cancellation of restricted stock
(13
)
 

 

 

 

 

 

 

 

 

Stock options exercised
20

 
0.5

 

 

 

 

 

 

 
0.5

 

Stock repurchased
(84
)
 
(6.1
)
 

 

 

 

 

 

 
(6.1
)
 

Share-based compensation

 
21.2

 

 

 

 

 

 

 
21.2

 

Tax benefit related to exercise of share-based awards

 
3.9

 

 

 

 

 

 

 
3.9

 

Dividends paid on preferred stock

 

 

 

 

 
(6.8
)
 

 

 
(6.8
)
 

Acquisitions and other transactions impacting noncontrolling interests

 
1.0

 

 

 

 

 

 
67.4

 
68.4

 
4.0

Distributions to noncontrolling interests, net of capital contributions

 

 

 

 

 

 

 
(56.4
)
 
(56.4
)
 
(114.6
)
Disposals and other transactions impacting noncontrolling interests

 
(4.3
)
 

 

 

 

 

 
(2.1
)
 
(6.4
)
 
0.5

Balance at September 30, 2016
54,804

 
$
1,361.6

 
1,725

 
$
166.6


$

 
$
891.5

 
$

 
$
534.4

 
$
2,954.1

 
$
177.9



See accompanying notes to the unaudited consolidated financial statements.
4